clinical trial · NCT06836557
Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis
Idiopathic GastroparesisDiabetic GastroparesisGastroparesisTradipitant
brief summary
This is a multicenter, open label, 3-month safety study with tradipitant in patients with idiopathic and diabetic gastroparesis.
started
Jan 9, 2024
primary completion
Dec 1, 2025
completion
Dec 1, 2025
last updated
Feb 20, 2025
official title
A Multicenter, Open Label, 3-Month Safety Study with Tradipitant in Patients with Idiopathic or Diabetic Gastroparesis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol